Form 4: Biomea Fusion Director Bihua Chen Reports Stock Option Grant and Beneficial Ownership
SEC Form 4
Director Bihua Chen reports acquisition of stock options and beneficial ownership of Biomea Fusion, Inc. shares through Cormorant Asset Management funds.
Summary
- Bihua Chen, a director of Biomea Fusion, Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report indicates that Chen acquired 51,025 stock options on June 12, 2024, with an exercise price of $4.63.
- These options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to Ms. Chen's continuing service to the Issuer through such vesting date.
- Chen also indirectly owns 3,570,872 shares of common stock through Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III, LP, and a managed account.
- Cormorant Asset Management, LP serves as the investment manager for these funds and the account.
- Chen disclaims beneficial ownership of these shares except to the extent of her pecuniary interest.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of options could be seen as mildly positive, but it's not a strong indicator.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Management Comments
- Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider ownership and potential alignment of interests.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of the stock option transaction |
| 06/13/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.